Citations

Clear

6273 citation(s) found for "To, Andrew".

Medial meniscus posterior root tears: A narrative review on the relationship and implications of meniscus extrusion
Geissbuhler, Annabel R. , Brophy, Robert H. , Krych, Aaron J., Seil, Romain , Kuhn, Andrew W. , Krych, Aaron J. , Brophy, Robert H. , Krych, Aaron J , Koga, Hideyuki , Seil, Romain , Kuhn, Andrew W

Mayo Clinic

Knee Surgery, Sports Traumatology, Arthroscopy | January 26, 2026 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.1002/ksa.70292 | PMID 41582723 Get It

Abstract Medial meniscus extrusion, particularly in the setting of medial meniscus posterior root tears (MMPRTs), has become an area of interest in recent years due to the correlation between meniscus extrusion with inferior clinical outcomes, progression to osteoarthritis, and increased rate of conversion to total knee arthroplasty after MMPRT repair. This correlation led to the development of meniscus centralisations procedures that can be performed in addition to MMPRT repair and/or high tibial osteotomy. Although it was originally thought that medial meniscus extrusion was a consequence of MMPRTs, it has been reported that meniscus extrusion often precedes the development of MMPRTs, which suggests that there may be underlying meniscus pathology that predisposes to the development of both meniscus extrusion and MMPRTs. The purpose of this narrative review is to provide an overview of the anatomy, pathology, and surgical management of meniscus extrusion and MMPRTs, while identifying areas of future research to further elucidate the relationship meniscus extrusion and MMPRTs that may be necessary to improve outcomes after MMPRT repair. Level of Evidence Level V.
Economic Evaluation of Tympanostomy Tube Placement
Brendes, Keith D. , Beckerman, Chase, Ritchey, Andrew , Page, Nathan C., Gerber, Mark E. , Ritchey, Andrew, Page, Nathan

Mayo Clinic

The Laryngoscope | January 24, 2026 | Volume: 136 | Issue: 6 | Pages: 2765-2768

10.1002/lary.70391 | PMID 41578617 Get It

ABSTRACT Objectives The purpose of this study is to compare the economics of in‐office tympanostomy tube placement using single use devices versus standard placement in the operating room (OR). Methods A retrospective chart review was completed for all pediatric patients who underwent in‐office tympanostomy tube placement (CPT 69433) along with insurance and date matched patients with placement in the OR (CPT 69436) between 12/1/21–3/1/24. Financial data were compared among the public vs. private insurance cohorts using the Wilcoxon rank‐sum test with a two‐sided significance level of 5%. Results One hundred and thirty‐six in‐office patients were identified, 102 private versus 34 public, and compared with 136 insurance and date matched OR patients. The average total payment for both privately insured patients, $647.14 in‐office versus $6873.45 in the OR, and publicly insured patients, $312.74 in‐office versus $2656.34 in the OR, was statistically significant. The average insurance payment for both privately insured patients, $301.58 in‐office versus $5445.73 in the OR, and publicly insured patients, $310.63 in‐office versus $2258.65 in the OR, was statistically significant. For the patient payment, public insurance usually has 0 copay and is therefore excluded. The patient payment of the private insurance cohort, $308.30 in‐office versus $670.61 in the OR, was not found to be statistically significant. Conclusion As expected, this study demonstrates significant reductions in overall cost with in‐office tympanostomy tube placement even with the added cost of single‐use devices compared to the standard placement in the OR, particularly for insurance companies, suggesting the potential benefit of providing reimbursement for these devices. Level of Evidence N/A.
AI-generated data contamination erodes pathological variability and diagnostic reliability
He, Hongyu , Xiang, Shaowen, Zhang, Y. P. , Zhu, Yingtao, Zhang, Jin, Lu, Yunyi, Deng, Hao, Alsentzer, Emily, Chen, Qingyu, Yu, Kun‐Hsing , Marshall, Andrew, Chen, Tingting, Anumasa, Srinivas, Ebner, Daniel, Ho, Dean, Cheng, Ching-Yu, Liu, Dianbo, Deng, Hao , Alsentzer, Emily , Liu, Yun , Chen, Qingyu , Yu, Kun‐Hsing , Chen, Tingting, Anumasa, Srinivas, Ebner, Daniel, Ho, Dean , Ngiam, Kee Yuan , Cheng, Ching-Yu

Mayo Clinic

No container title available | January 22, 2026 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.64898/2026.01.19.26344383 Get It

Abstract Generative artificial intelligence (AI) is rapidly populating medical records with synthetic or partially AI-generated content, creating a feedback loop where future models are increasingly at risk of training on uncurated AI-generated data. However, the clinical consequences of this AI-generated data contamination remain unexplored. Here, we show that in the absence of mandatory human verification, this self-referential cycle drives a rapid erosion of pathological variability and diagnostic reliability of medical data at population scale. By analysing more than 800,000 synthetic data points across clinical text generation, vision–language reporting, and medical image synthesis, we find that models progressively converge toward generic phenotypes regardless of the model architectures. Specifically, rare but critical findings, including pneumothorax and effusions, vanish from the synthetic content generated by AI models, while demographic representations skew heavily toward middle-aged male phenotypes. Crucially, this degradation is masked by false diagnostic confidence. Models continue to issue reassuring reports while failing to detect life-threatening pathology, with false reassurance rates tripling to 40%. Blinded physician evaluation confirms that this decoupling of confidence and accuracy renders AI-generated documentation clinically useless after just two generations. We systematically evaluate three mitigation strategies that can be easily integrated into existing clinical workflows, finding that while synthetic volume scaling fails to prevent collapse, mixing real data with quality-aware filtering effectively preserves diversity. Ultimately, our results suggest that without policy-mandated human oversight, the deployment of generative AI threatens to degrade the very healthcare data ecosystems it relies upon.
Prognostic factors for 90-day survival after stereotactic radiosurgery for brain metastasis patients
Loron, Ali Gharibi , Chow, William, Pumford, Andrew D., Zhao, Conan , Keough, Michael B. , You, Hyo Bin , Do, Bobby, Schwartz, Jenna , Foote, Robert L., Mahajan, Anita , Stien, Kathy J., Link, Michael J., Yan, Elizabeth Mary, Brown, Paul D., Pollock, Bruce E., Parney, I., Chow, William D, Zhao, Conan Y, Pumford, Andrew D. , Foote, Robert L. , Routman, David M. , Link, Michael J. , Burns, Terry C. , Yan, Elizabeth, Pollock, Bruce E.

Mayo Clinic

Journal of Neurosurgery | January 22, 2026 | Volume: 144 | Issue: 4 | Pages: 979-987

10.3171/2025.8.jns25859 | PMID 41569738 Get It

OBJECTIVE Brain metastases significantly impact neurocognitive function and overall survival. Stereotactic radiosurgery (SRS) is a cornerstone of treatment for patients with limited metastases and expected survival beyond 3 months. Despite current guidelines, up to 20% of patients with brain metastases undergoing SRS have been reported to die within 90 days. This study retrospectively evaluated prognostic factors associated with 90-day survival after SRS, aiming to improve patient selection. METHODS The authors retrospectively analyzed a cohort of 1546 patients who underwent Gamma Knife SRS for brain metastases at their institution between 2015 and 2023. One hundred seventy patients who survived less than 90 days after SRS were identified and case matched to 170 patients who survived over 90 days. Measured variables included patient demographic characteristics, tumor characteristics, treatment history, functional status, and control of the primary cancer. The authors modeled post-SRS 90-day survival using binomial and multivariate logistic regression. RESULTS Multivariate analysis highlighted Karnofsky Performance Score (KPS) < 70 (OR 17.4, p < 0.001), prior whole-brain radiation (OR 6, p = 0.004), and focal neurological deficits (OR 3.02, p = 0.003) as significant predictors of poor survival, whereas CNS progression before SRS (OR 0.22, p < 0.001) and control of systemic cancer (OR 0.556, p = 0.002) were associated with survival < 90 days. The predictive model demonstrated acceptable performance with an area under the curve (AUC) of 0.85, accuracy of 80%, sensitivity of 87%, and specificity of 71%. CONCLUSIONS Key predictors of 90-day survival after SRS for brain metastases include functional status (KPS), control of systemic cancer, CNS progression status, and focal neurological deficits. These findings are complementary factors that can assist in making decisions and SRS patient selection.
Impact of Sleep Positioning Device on Acid Exposure and Outcomes in Lung Transplant Recipients With Gastroesophageal Reflux Disease
Aggarwal, Manik , Thuita, Lucy , Greathouse, Tyler, Rappaport, Jesse , Kichler, Adam, Arora, Zubin , Qin, Yi, Akindipe, Olufemi, Tang, Andrew , Murthy, SC, Lane, Charles, Budev, Marie, Ahmad, Usman, Gabbard, Scott , Lane, Charles Randall, Budev, Marie , Ahmad, Usman

Mayo Clinic

Journal of Clinical Gastroenterology | January 21, 2026 | Volume: 60 | Issue: 7 | Pages: 619-625

10.1097/mcg.0000000000002300 | PMID 41564033 Get It

Introduction: Gastroesophageal reflux disease (GERD) plays an important role in lung transplant (LT) outcomes. This study aims to evaluate the impact of a novel sleep positioning device (SPD) on lung function in LT recipients with GERD. Methods: In this single-center cohort study, LT recipients (2014 to 2019) with GERD who were prescribed an SPD within 2 years of LT were included. A historical control group of LT recipients with GERD on PPI only (2011 to 2013) was selected to compare forced expiratory volume in 1 second (FEV1) as a marker of lung function. Results: Twenty LT recipients using SPD (cases) and 54 patients in the historical control group with proven GERD were included. Mean (SD) interval between LT and SPD prescription was 8.6 (5.7) months. Mean % predicted FEV1 was higher in SPD users than controls post-LT at 6 months (80% vs. 69%) and 1 year (80% vs. 71%), respectively. Among SPD users, post-SPD FEV1 was higher than pre-SPD FEV1 (82% vs. 70%). Conclusion: Use of a novel SPD can stabilize or improve pulmonary function in patients with GERD after LT. SPD may be a safe and cost-effective adjunctive therapy for the management of GERD after LT.
Akuamma Seed ( Picralima nitida ) Use in the U.S.: Findings from a Web-Based Survey
Timmons, Patricia , Hill, Katherine , Smith, Kirsten E., Riley, Andrew, Mun, Chung Jung, Smith, Kirsten Elin , Mun, Chung Jung

Mayo Clinic

Journal of Psychoactive Drugs | January 21, 2026 | Volume: No volume available | Issue: No issue available | Pages: 1-8

10.1080/02791072.2026.2618033 | PMID 41563345 Get It

Outcomes of Hip Arthroscopy in Patients With Acetabular Cysts: A Multicenter Matched Controlled Study From the MASH Study Group
Matsuda, Dean, Wolff, Andrew B. , Nho, Shane, Christoforetti, John J. , Salvo, John P. , Martin, RobRoy L., McGovern, Ryan P. , Silk, Richard J., Ishimoto, Allysa, Ko, Brandon, Matsuda, Dean K. , Martin, RobRoy L. , Carreira, Dominic S.

Mayo Clinic

The American Journal of Sports Medicine | January 21, 2026 | Volume: 54 | Issue: 2 | Pages: 424-430

10.1177/03635465251405731 | PMID 41562523 Get It

Background: Some studies have reported more severe chondral pathology and less successful hip arthroscopic outcomes in patients with acetabular subchondral cysts. Purpose/Hypothesis: The purpose of this study was to report multicenter arthroscopic outcomes of patients with and without acetabular bone cysts. It was hypothesized that patients with acetabular cysts would demonstrate inferior outcomes at minimum 2-year follow-up compared with patients without acetabular cysts. Study Design: Cohort study; Level of evidence, 3. Methods: A multicenter matched-pair study was performed across 6 medical centers with data from a large prospectively collected database. Inclusion criteria were adult patients who had undergone primary unilateral hip arthroscopy for femoroacetabular impingement syndrome (FAIS). The study group was defined by the presence of a superolateral acetabular subchondral cyst on preoperative imaging. A control group was matched on age; sex; body mass index (BMI); lateral center-edge angle (LCEA); alpha angle; arthroscopic treatments of femoroplasty, acetabuloplasty, and labral treatment (ie, repair, reconstruction, or debridement); Beck chondral grade; and minimum 2-year outcomes using visual analog scale (VAS) for pain, International Hip Outcome Tool-12 (iHOT-12), minimal clinically important difference (MCID), substantial clinical benefit (SCB), and Patient Acceptable Symptom State (PASS). Results: The study included 82 patients, of whom 41 composed the study group and 41 served as matched control patients. The study group had a mean age of 42.16 ± 11.26 years with 48.78% women and a mean BMI of 26.51 ± 4.31 kg/m 2 . Mean LCEA was 33.55°± 6.30°, and mean alpha angle was 70.22°± 9.71°. Mean Beck chondral grade was 2.59 ± 1.27 in the study group and 2.70 ± 0.95 in the matched control group ( P = .72). Two-year mean postoperative iHOT-12 scores for the study and control groups were 69.49 ± 24.51 and 73.24 ± 25.16, respectively ( P = .38), whereas mean postoperative VAS scores for pain were 18.84 ± 18.17 and 20.74 ± 21.39, respectively ( P = .70). The study group reached MCID in 82.93%, SCB in 58.54%, and PASS in 65.85% and were similar to those of the control group. Conclusion: Patients undergoing arthroscopic surgery for FAIS with acetabular cysts had similarly successful outcomes as patients without acetabular cysts. Acetabular subchondral cysts may not be a contraindication to hip arthroscopy in patients with FAIS who would otherwise be indicated for this surgery.
A Pilot Study Using a Portable Electromyography Device to Assess Changes in Compound Muscle Action Potential Amplitudes and Latencies in Critically Ill Intubated Patients
Greenberg, Steven B., Locke, Andrew R. , Ben-Isvy, Noah, Bochenek, Andrew, Wlodarski, Richard, Brull, Sorin J.

Mayo Clinic

Anesthesiology | January 21, 2026 | Volume: 144 | Issue: 3 | Pages: 715-719

10.1097/aln.0000000000005845 | PMID 41562465 Get It

EMERGE Mothers and Kids: A Longitudinal Cohort Study of Mothers and Children Enrolled in the Randomized Placebo-Controlled Trial of Metformin in Women with GDM (EMERGE): study protocol
Newman, Christine, Smyth, Andrew, o'Shea, Paula, Gillespie, Paddy, Dunne, Fidelma P, O’Shea, Paula , O'Shea, Paula M , Scairati, Roberta , Newman, Christine , Alvarez‐Iglesias, Alberto , Smyth, Andrew , Devane, Declan , Gillespie, Paddy , Egan, Aoife M. , O’Donnell, Martin , Dunne, Fidelma

Mayo Clinic

No container title available | January 20, 2026 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.21203/rs.3.rs-7632300/v1 Get It

Abstract Background Pregnancies complicated by gestational diabetes mellitus (GDM) are associated with increased risks of adverse perinatal outcomes, and with long-term metabolic and cardiovascular consequences for both mother and child. The original EMERGE randomized controlled trial (RCT) evaluated the effectiveness of early metformin in addition to usual care in women with GDM on glycaemic control and perinatal outcomes. The EMERGE Mothers and Kids study is a longitudinal follow-up of the EMERGE trial participants, designed to investigate the long-term metabolic, cardiovascular, and neurodevelopmental outcomes in mothers and their offspring. Methods This is a prospective, observational cohort study of participants and their children from the EMERGE trial (NCT06327191). A single follow-up visit will be conducted up to 6 years after the index pregnancy. Maternal assessments include anthropometric data, glucose tolerance, and metabolic parameters. Child assessments include growth metrics, adiposity measured via skinfold thickness, and neurodevelopmental status assessed through validated questionnaires. Additional data on quality of life, mental health, breastfeeding, and health economics will also be collected. Discussion This study aims to provide insights into the long-term safety and efficacy of metformin use during pregnancy and its potential impact on the long term maternal and child health outcomes, contributing to evidence-based management of GDM. Trial registration: ClinicalTrials.gov; Identifier: NCT06327191